These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16863635)

  • 21. Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.
    Bogaisky M
    Am J Geriatr Psychiatry; 2014 Sep; 22(9):951. PubMed ID: 25109421
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of the elderly dementia patients].
    Takeda M; Shinosaki K; Nishikawa T; Tanaka T; Kudo T; Nakamura Y; Kashiwagi Y
    Nihon Ronen Igakkai Zasshi; 2000 Nov; 37(11):879-81. PubMed ID: 11193359
    [No Abstract]   [Full Text] [Related]  

  • 23. Combination of risperidone and donepezil in Lewy body dementia.
    Geizer M; Ancill RJ
    Can J Psychiatry; 1998 May; 43(4):421-2. PubMed ID: 9598283
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil and galantamine.
    Capellà D; Vidal X
    Age Ageing; 2007 Mar; 36(2):234; author reply 235. PubMed ID: 17255086
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine.
    López-Pousa S; Olmo JG; Franch JV; Estrada AT; Cors OS; Nierga IP; Gelada-Batlle E
    Age Ageing; 2006 Jul; 35(4):365-71. PubMed ID: 16788079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galantamine vs donepezil in the treatment of Alzheimer's disease.
    Goldlist B; Gordon M; Naglie G
    Drugs Aging; 2003; 20(15):1139-40; author reply 1140. PubMed ID: 14651439
    [No Abstract]   [Full Text] [Related]  

  • 27. Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
    Freund-Levi Y; Bloniecki V; Auestad B; Tysen Bäckström AC; Lärksäter M; Aarsland D
    Dement Geriatr Cogn Disord; 2014; 38(3-4):234-44. PubMed ID: 24969380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and tolerability of galantamine SA in dementia patients transitioned from donepezil.
    Rosenbloom MH; Brown J; Berlowitz DR; Budson AE
    Consult Pharm; 2011 Feb; 26(2):108-10. PubMed ID: 21310708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
    Black S; Román GC; Geldmacher DS; Salloway S; Hecker J; Burns A; Perdomo C; Kumar D; Pratt R;
    Stroke; 2003 Oct; 34(10):2323-30. PubMed ID: 12970516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug-cholinesterase-inhibitors persistence patterns in treated patients with dementia of Alzheimer type: retrospective comparative analysis of donepezil, rivastigmine and galantamine].
    Sicras A; Rejas-Gutiérrez J
    Rev Neurol; 2004 Aug 16-31; 39(4):312-6. PubMed ID: 15340887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switching from donepezil to galantamine: a double-blind study of two wash-out periods.
    Wilkinson DG; Howe I
    Int J Geriatr Psychiatry; 2005 May; 20(5):489-91. PubMed ID: 15852437
    [No Abstract]   [Full Text] [Related]  

  • 32. [Latest therapies for treating dementia].
    González Moneo MJ; Garrido Barral A
    Aten Primaria; 2002 May; 29(8):507-12. PubMed ID: 12031225
    [No Abstract]   [Full Text] [Related]  

  • 33. Extrapyramidal side effects in a patient treated with risperidone plus donepezil.
    Magnuson TM; Keller BK; Burke WJ
    Am J Psychiatry; 1998 Oct; 155(10):1458-9. PubMed ID: 9766783
    [No Abstract]   [Full Text] [Related]  

  • 34. Galantamine improves sleep quality in patients with dementia.
    Naharci MI; Ozturk A; Yasar H; Cintosun U; Kocak N; Bozoglu E; Tasci I; Doruk H
    Acta Neurol Belg; 2015 Dec; 115(4):563-8. PubMed ID: 25777522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An unsubstantiated conclusion.
    Reifler BV; Blazer D
    Am J Geriatr Psychiatry; 2015 Feb; 23(2):220. PubMed ID: 25575935
    [No Abstract]   [Full Text] [Related]  

  • 36. Can donepezil be considered a mild antipsychotic in dementia treatment? A report of donepezil use in 6 patients.
    Terao T; Shimomura T; Nakamura J
    J Clin Psychiatry; 2003 Nov; 64(11):1392-3. PubMed ID: 14658957
    [No Abstract]   [Full Text] [Related]  

  • 37. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2013 Oct; 11(134):95-100; quiz 1 p following p100.. PubMed ID: 24081314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of donepezil on tardive dyskinesia.
    Ogunmefun A; Hasnain M; Alam A; Osuala T; Regenold WT
    J Clin Psychopharmacol; 2009 Feb; 29(1):102-4. PubMed ID: 19142126
    [No Abstract]   [Full Text] [Related]  

  • 39. Response to Bogaiksy's letter to the editor.
    Freund-Levi Y; Jedenius E; Wahlund LO; Eriksdotter M; Tysen-Bäckström AC; Lärksäter M
    Am J Geriatr Psychiatry; 2014 Sep; 22(9):951. PubMed ID: 25109420
    [No Abstract]   [Full Text] [Related]  

  • 40. Sleep-related eating disorder induced by risperidone.
    Lu ML; Shen WW
    J Clin Psychiatry; 2004 Feb; 65(2):273-4. PubMed ID: 15003084
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.